These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17055410)

  • 1. Diagnostic challenges for multiplexed protein microarrays.
    Master SR; Bierl C; Kricka LJ
    Drug Discov Today; 2006 Nov; 11(21-22):1007-11. PubMed ID: 17055410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long and difficult road to the diagnostic market: protein microarrays.
    Joos TO; Berger H
    Drug Discov Today; 2006 Nov; 11(21-22):959-61. PubMed ID: 17055403
    [No Abstract]   [Full Text] [Related]  

  • 3. Validation and quality control of protein microarray-based analytical methods.
    Kricka LJ; Master SR
    Methods Mol Med; 2005; 114():233-55. PubMed ID: 16156108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiconductor quantum dots for multiplexed bio-detection on solid-state microarrays.
    Rousserie G; Sukhanova A; Even-Desrumeaux K; Fleury F; Chames P; Baty D; Oleinikov V; Pluot M; Cohen JH; Nabiev I
    Crit Rev Oncol Hematol; 2010 Apr; 74(1):1-15. PubMed ID: 19467882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein microarrays in diagnosing IgE-mediated diseases: spotting allergy at the molecular level.
    Harwanegg C; Hiller R
    Expert Rev Mol Diagn; 2004 Jul; 4(4):539-48. PubMed ID: 15225101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed sandwich assays in microarray format.
    Nielsen UB; Geierstanger BH
    J Immunol Methods; 2004 Jul; 290(1-2):107-20. PubMed ID: 15261575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the diagnostic performance of human whole genome microarrays using mixed-tissue RNA reference samples.
    Thompson KL; Pine PS
    Toxicol Lett; 2009 Apr; 186(1):58-61. PubMed ID: 18822358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments.
    Rème T; Hose D; De Vos J; Vassal A; Poulain PO; Pantesco V; Goldschmidt H; Klein B
    BMC Bioinformatics; 2008 Jan; 9():16. PubMed ID: 18190711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker discovery using protein microarray technology platforms: antibody-antigen complex profiling.
    Mattoon D; Michaud G; Merkel J; Schweitzer B
    Expert Rev Proteomics; 2005 Dec; 2(6):879-89. PubMed ID: 16307517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What does it need to be a biomarker? Relationships between resolution, differential quantification and statistical validation of protein surrogate biomarkers.
    Schrattenholz A; Groebe K
    Electrophoresis; 2007 Jun; 28(12):1970-9. PubMed ID: 17516580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in diagnostic technologies for autoimmune diseases.
    Plebani M; Pittoni M; Celadin M; Bernardi D; Mion MM
    Autoimmun Rev; 2009 Jan; 8(3):238-43. PubMed ID: 18718878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chip-based miniaturized format for protein-expression profiling: the exploitation of comprehensively produced antibodies.
    Koga H; Kyo M; Usui-Aoki K; Inamori K
    Electrophoresis; 2006 Sep; 27(18):3676-83. PubMed ID: 16915563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein arrays for biomarker discovery.
    Reid JD; Parker CE; Borchers CH
    Curr Opin Mol Ther; 2007 Jun; 9(3):216-21. PubMed ID: 17608019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of sandwich ELISA microarrays with minimal assay interference.
    Gonzalez RM; Seurynck-Servoss SL; Crowley SA; Brown M; Omenn GS; Hayes DF; Zangar RC
    J Proteome Res; 2008 Jun; 7(6):2406-14. PubMed ID: 18422355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of peptide epitope microarray experiments and extraction of quality data.
    Nahtman T; Jernberg A; Mahdavifar S; Zerweck J; Schutkowski M; Maeurer M; Reilly M
    J Immunol Methods; 2007 Dec; 328(1-2):1-13. PubMed ID: 17765917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case studies from the use of commercial biomarker/protein test kits.
    Beaver CJ; Roby-Peters SK
    Bioanalysis; 2011 Aug; 3(16):1867-75. PubMed ID: 21877896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein microarrays: effective tools for the study of inflammatory diseases.
    Yu X; Schneiderhan-Marra N; Hsu HY; Bachmann J; Joos TO
    Methods Mol Biol; 2009; 577():199-214. PubMed ID: 19718518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data processing and analysis for protein microarrays.
    DeLuca DS; Marina O; Ray S; Zhang GL; Wu CJ; Brusic V
    Methods Mol Biol; 2011; 723():337-47. PubMed ID: 21370075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attomolar protein detection in complex sample matrices with semi-homogeneous fluidic force discrimination assays.
    Mulvaney SP; Myers KM; Sheehan PE; Whitman LJ
    Biosens Bioelectron; 2009 Jan; 24(5):1109-15. PubMed ID: 18656344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.